Arch Biopartners Inc.

OTCPK:ACHF.F Stock Report

Market Cap: US$24.0m

Arch Biopartners Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:ACHF.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Apr 26BuyUS$35,214Richard MuruveIndividual81,667US$0.43
11 Feb 26BuyUS$337Richard MuruveIndividual500US$0.67
06 Feb 26BuyUS$15,282Richard MuruveIndividual21,650US$0.79
02 Feb 26SellUS$51,901Richard RossmanIndividual100,000US$0.52
07 Jan 26SellUS$9,151Richard MuruveIndividual10,000US$0.92
02 Jan 26SellUS$3,584Richard MuruveIndividual4,000US$0.90
19 Dec 25SellUS$9,145Richard MuruveIndividual10,000US$0.91
18 Nov 25BuyUS$357,165Richard MuruveIndividual480,923US$0.74
06 Nov 25SellUS$95,572Richard MuruveIndividual130,000US$0.76
04 Nov 25SellUS$73,144Richard MuruveIndividual100,000US$0.73
12 Sep 25SellUS$5,000Richard MuruveIndividual4,200US$1.19
02 Sep 25SellUS$12,111Richard MuruveIndividual10,000US$1.21
28 Aug 25SellUS$12,062Richard MuruveIndividual10,000US$1.21
27 Aug 25SellUS$24,084Richard MuruveIndividual20,000US$1.21
12 Aug 25SellUS$6,324Richard MuruveIndividual5,000US$1.26
03 Jul 25BuyUS$9,697Richard MuruveIndividual7,500US$1.31
20 Jun 25BuyUS$3,814Richard MuruveIndividual3,000US$1.27

Insider Trading Volume

Insider Buying: ACHF.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ACHF.F?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders15,004,24922.1%
General Public52,929,04077.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 5 shareholders own 22.09% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.8%
Richard Muruve
10,042,750US$3.5m0.82%no data
3.01%
Daniel Muruve
2,047,619US$722.0k0%no data
2.87%
Richard Rossman
1,952,280US$688.4k-4.87%no data
1.15%
Andrew Bishop
780,000US$275.0k0%no data
0.27%
Patrick Vink
181,600US$64.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/14 23:20
End of Day Share Price 2026/06/12 00:00
Earnings2026/03/31
Annual Earnings2025/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Arch Biopartners Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rahul SarugaserRaymond James Ltd.